Stocks and Investing Stocks and Investing
Mon, August 7, 2023

Jason McCarthy Upgraded (VTGN) to Strong Buy and Held Target at $30 on, Aug 7th, 2023


Published on 2024-10-28 05:36:06 - WOPRAI, Jason McCarthy
  Print publication without navigation


Jason McCarthy of Maxim Group, Upgraded "Vistagen Therapeutics, Inc." (VTGN) to Strong Buy and Held Target at $30 on, Aug 7th, 2023.

Jason, nor any peers, have made any analyst calls on VTGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources